(Reuters) - The city of Baltimore won $266 million in its lawsuit accusing top drug distributors McKesson and Cencora of fueling an epidemic of opioid addiction in the U.S., and is expected to seek billions more in the next phase of the case.

Jury deliberations in Baltimore’s opioid case against two drug distribution companies will stretch into next week.

There’s another phase to the trial — and likely appeals — after Tuesday’s verdict. The city has laid out a plan to spend settlements over the next 15 years.

A jury on Tuesday ruled in favor of the City of Baltimore, finding that two drug distribution companies fueled the opioid epidemic in the city by sending hundreds of millions of painkillers here, and awarded $274 million in damages. The jury began ...